Chemomab touts study confirming CCL24 link to systemic sclerosis severity
Higher CCL24 levels in systemic sclerosis patients have been linked to more severe forms of the condition.
Ocado WP
OncoX inks licensing deal worth over $26m for NSCLC therapy
Theolytics secures funds to advance oncolytic adenovirus therapy
Ultimovacs downsizes to funnel funds to cancer vaccine programme
Johnson & Johnson reports net earnings of $5.3bn in Q1 2024
TetraScience and Google Cloud link for AI-driven drug developments
Drug delivery innovations push forth women’s health
Harnessing pharmacovigilance to turn reactive investigation into active discovery
